These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12378293)

  • 1. Control of human African trypanosomiasis in the Quiçama focus, Angola.
    Ruiz JA; Simarro PP; Josenando T
    Bull World Health Organ; 2002; 80(9):738-45. PubMed ID: 12378293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea.
    Simarro PP; Franco JR; Ndongo P; Nguema E; Louis FJ; Jannin J
    Trop Med Int Health; 2006 May; 11(5):636-46. PubMed ID: 16640616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan.
    Chappuis F; Stivanello E; Adams K; Kidane S; Pittet A; Bovier PA
    Am J Trop Med Hyg; 2004 Sep; 71(3):313-7. PubMed ID: 15381812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease.
    Truc P; Lando A; Penchenier L; Vatunga G; Josenando T
    Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A strategy to control Trypanosomiasis due to Trypanosoma brucei gambiense in an endemic region of Zaire. Association of a serological test and early treatment of suspected cases. Preliminary results].
    De Groof D; Bruneel H; Mungoma K; Ruppol JF
    Bull Soc Pathol Exot; 1993; 86(4):260-3. PubMed ID: 8292915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
    Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P
    Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
    Miezan TW; Dje NN; Doua F; Boa F
    Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
    Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
    Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
    Buguet A; Bisser S; Josenando T; Chapotot F; Cespuglio R
    Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa.
    Truc P; Lejon V; Magnus E; Jamonneau V; Nangouma A; Verloo D; Penchenier L; Büscher P
    Bull World Health Organ; 2002; 80(11):882-6. PubMed ID: 12481210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
    Eperon G; Schmid C; Loutan L; Chappuis F
    Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retaking sleeping sickness control in Angola.
    Abel PM; Kiala G; Lôa V; Behrend M; Musolf J; Fleischmann H; Théophile J; Krishna S; Stich A
    Trop Med Int Health; 2004 Jan; 9(1):141-8. PubMed ID: 14728618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
    Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the reactivity of the card agglutination test for trypanosomiasis (CATT) reagent in the Fontem sleeping sickness focus, Cameroon.
    Asonganyi T; Bedifeh BA; Ade SS; Ngu JL
    Afr J Med Med Sci; 1994 Mar; 23(1):39-46. PubMed ID: 7839945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CATT negative result after treatment for human African trypanosomiasis is no indication for cure.
    Lejon V; Ngoyi DM; Boelaert M; Büscher P
    PLoS Negl Trop Dis; 2010 Jan; 4(1):e590. PubMed ID: 20126270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).
    Schmid C; Richer M; Bilenge CM; Josenando T; Chappuis F; Manthelot CR; Nangouma A; Doua F; Asumu PN; Simarro PP; Burri C
    J Infect Dis; 2005 Jun; 191(11):1922-31. PubMed ID: 15871127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scourge of human African trypanosomiasis.
    Cattand P
    Afr Health; 1995 Jul; 17(5):9-11. PubMed ID: 12319651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological, clinical and sociodemographic characteristics of human African trypanosomiasis (HAT) in and around Kinshasa, Democratic Republic of Congo].
    Tshimungu K; Okenge LN; Mukeba JN; Kande VB; De Mol P
    Sante; 2009; 19(2):73-80. PubMed ID: 20031514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.